ai-one and ibiomics Launch Genomic Sequencing Company

A new joint venture with computational biologist Prof. Dr. Peter Beyerlein, positions ai-one technology at leading edge of genomic sequencing revolution in healthcare.
By: Tom Marsh
 
April 4, 2011 - PRLog -- La Jolla CA | Zurich | Berlin ai-one inc., a provider of software development technology (SDK) for semantic associative search and the development of learning machines has announced the formation of a new venture with Prof. Dr. Peter Beyerlein and ibiomics gmbh.

According to Prof. Dr. Beyerlein, “With our sequencing solutions we are bringing a new diagnostic modality into the clinics, which will have a similar impact and growth rate as we have seen in the 1970s with the introduction of the MRT (magnetic resonance tomography).”

ai-ibiomics gmbh, a joint venture in genomic sequencing has been completed and the company is moving rapidly toward product launch in mid 2011.  Lead by CEOs Prof. Dr. Peter Beyerlein and Dr. Markus A. Zoller, the company intends to be the first mover and future market leader in high speed IT-based genomic diagnostics with the first full scale modeling of individuals and the most sophisticated cause-and-effect-based personal healthcare. This field is the future of medicine and the computational challenges are uniquely suited to the strengths of ai-one technology.

The Berlin-Brandenburg based joint venture brings together ai-one technology with the staff and expertise of ibiomics gmbh.  ibiomics was a startup at Technical University of Applied Sciences Wildau where they developed a new generation of biomedical diagnostic procedures for clinical use. Their expertise in mathematical biology, combined with superior reproducibility and the dynamic range of high throughput sequencing technologies, enables disease understanding and medical decision support with unprecedented precision and confidence.

The company will launch in Germany the first full-fledged autonomous sequencing center offering a set of services such as full exome and full transcriptome sequence diagnostic services, from tissue to educated decision support.  More information is available at http://www.ai-ibiomics.de/

# # #

About ai-one inc., ai-one provides an “API for building learning machines”. Based in San Diego, Zurich and Berlin, ai-one’s software technology is an adaptive holosemantic data space with semiotic capabilities (“biologically inspired intelligence”). The Topic-Mapper™ SDK for text enables developers to create intelligent applications that deliver better sense-making capabilities for semantic discovery, lightweight ontologies, knowledge collaboration, sentiment analysis, artificial intelligence and data mining.
End
Source:Tom Marsh
Email:***@ai-one.com Email Verified
Zip:92037
Tags:Artificial Intelligence, Bioinformatics, Biotech, ai, Genomic Sequencing, Transcriptome, Medicine, Diagnostic
Industry:Health, Medical, Research
Location:La Jolla - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Apr 08, 2011



Like PRLog?
9K2K1K
Click to Share